Biomarkers in graft-versus-host disease: from prediction and diagnosis to insights into complex graft/host interactions
FC He, SG Holtan - Current hematologic malignancy reports, 2018 - Springer
Abstract Purpose of Review Acute graft versus host disease (aGVHD) is a frequent cause of
treatment-related mortality after allogeneic hematopoietic stem cell transplantation …
treatment-related mortality after allogeneic hematopoietic stem cell transplantation …
[HTML][HTML] Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid
Amphiregulin, a weak epidermal growth factor receptor agonist, is elevated, while epidermal
growth factor, a strong epidermal growth factor receptor agonist, is low in the blood of …
growth factor, a strong epidermal growth factor receptor agonist, is low in the blood of …
High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
B Schultz, DD Miller, T DeFor, BR Blazar… - Journal of cutaneous …, 2022 - Wiley Online Library
Background Amphiregulin (AREG) is increased in circulation in acute graft‐versus‐host
disease (aGVHD) and is associated with poor steroid response and lower survival. The …
disease (aGVHD) and is associated with poor steroid response and lower survival. The …